Abstract # 2367 Defining the Risk of Developing Grade 2 Proctitis Following Combined Modality Therapy using a Rectal Dose-volume Histogram Analysis and Biologic Equivalent Dose

Presenter: Snyder, Kurt

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

K. M. Snyder, V. M. Skouteris, N. N. Stone, J. A. Cesaretti, R. G. Stock, Mount Sinai Medical Center, NY, NY

Author Disclosure:
 K.M. Snyder, None; V.M. Skouteris, None; N.N. Stone, Prologics LLC, E. Ownership Interest; Nihon MediPhysics, F. Consultant/Advisory Board; J.A. Cesaretti, CR Bard Lecturer, G. Other; R.G. Stock, CR Bard Lecturer, G. Other.

E-mail a friend about this abstract:
Enter email address: